About our research

  The cancer death rate is increasing every year, mostly due to invasion and metastasis. Accordingly, overcoming cancer invasion and metastasis should be the top priority in today’s cancer research. To this end, we need solid basic studies on molecular and cellular mechanisms of invasion and metastasis, and simultaneous efforts on developing novel therapeutic measures.
  We have been studying mechanisms of colon cancer development and progression using various mouse models. Our recent focuses include interaction between cancer cells and microenvironment, metastasis, and personalized medicine using the patient-derived xenograft (PDX) and the patient-derived spheroid models.




            

What's new

2019/01/15
Publications has been updated.
2017/09/28
Dr. Kakizaki has received the Cancer Science Young Scientists Award 2017.
2017/03/22
Publications has been updated.
2016/06/01
Former Department of Pharmacology was renewed as Division of Experimental Therapeutics.
2015/08/24
New HomePage was updated.